| Patent No. | Patent Title: |
| 8153426 | Preparation of antigen-presenting human gamma-delta T cells and u... |
| 8128922 | Superior molecular vaccine linking the translocation domain of a ... |
| 8105608 | Method of treatment using ligand-immunogen conjugates |
| 8093216 | Method of treating cancer by inhibition of p95HER-2 production |
| 8007991 | Three-dimensional physiological matrices for oncological testing,... |
| 7993638 | Cancer treatment combining lymphodepleting agent with CTLs and cy... |
| 7976846 | Stress protein compositions and methods for prevention and treatm... |
| 7977041 | Methods and kits for testing the efficacy of therapeutic compound... |
| 7972769 | Method for preparing cell cultures from biological specimens for ... |
| 7968308 | Isolating human antibodies |
| 7955590 | Fc fusion proteins for enhancing the immunogenicity of protein an... |
| 7951405 | Combined treatment with cisplatin and an epidermal growth factor ... |
| 7951356 | Tissue factor compositions and kits for coagulation and tumor tre... |
| 7951365 | Method for expansion of tumour-reactive T-lymphocytes for immunot... |
| 7947463 | Compositions and methods for the diagnosis, treatment and prevent... |
| 7939293 | Method for producing carboxy-terminal-amidified peptides |
| 7927612 | Combinations and methods for treating neoplasms |
| 7923460 | mutation T1796A in thyroid cancers |
| 7919314 | Process for the production of monoclonal antibodies |
| 7897147 | Treatment of premenstrual disorders |
| 7897139 | PTHrP, its isoforms and antagonist thereto in the diagnosis and t... |
| 7893023 | Prodrugs activated by plasmin and their use in cancer chemotherap... |
| 7892530 | Treatment of tumor metastases and cancer |
| 7893026 | Treatment of EGFR-dependent tumors by ABIN (a20 -binding inhibito... |
| 7888320 | Composition for treating cancer adapted for intra-tumoral adminis... |
| 7883841 | Methods and kits for testing the efficacy of therapeutic compound... |
| 7879335 | Glycoconjugates, glycoamino acids, intermediates thereto, and use... |
| 7871630 | Therapeutic modulation of the tumor inflammatory response |
| 7854934 | Glycoconjugates, glycoamino acids, intermediates thereto, and use... |
| 7851213 | Tumor antigens BFA4 and BCY1 for prevention and / or treatment of... |
| 7842458 | Nucleic acids and corresponding proteins entitled 58P1D12 useful ... |
| 7837990 | In vivo expanded NKT cells and methods of use thereof |
| 7838495 | Compositions and methods of use of EPB1, and ErbB3 binding protei... |
| 7833698 | Method for determining the response to cancer therapy |
| 7829064 | Anti-CD74 immunoconjugates and methods |
| 7824687 | Clustered multi-antigenic carbohydrate constructs, methods for th... |
| 7807383 | Diagnosing and treating hormone resistant cancers |
| 7807782 | Method for linking molecular substances |
| 7807186 | Tumor cells from immune privileged sites as base cells for cell-b... |
| 7803408 | Method of treating endothelial injury |
Bizarre Patents 
PatentStorm News
